Abstract
Novel drug delivery systems (NDDS) delivered the active molecules to the target site in a defined manner for produce the desired effects without disturbing the delicate bio-environment. Among many available colloidal drug delivery systems, Liposomes (a class based on phospholipids) have attracted more attention than other systems due to many meritorious features such as excellent chemical & biological stability, good solubilisation power, promote intracellular delivery of bio-active molecules, reduce the uptake of macrophages and encapsulate both hydrophilic as well as lipophillic drug molecule. In this review article, I try to give some basic knowledge about these carrier systems in tabular form, which is more understandable concept as compared to simple text form.
Keywords: Cell delivery, drug targeting, gene delivery, liposome, phospholipids.
Drug Delivery Letters
Title:Liposomes: Targeted and Controlled Delivery System
Volume: 4 Issue: 1
Author(s): Tarun Garg and Amit K. Goyal
Affiliation:
Keywords: Cell delivery, drug targeting, gene delivery, liposome, phospholipids.
Abstract: Novel drug delivery systems (NDDS) delivered the active molecules to the target site in a defined manner for produce the desired effects without disturbing the delicate bio-environment. Among many available colloidal drug delivery systems, Liposomes (a class based on phospholipids) have attracted more attention than other systems due to many meritorious features such as excellent chemical & biological stability, good solubilisation power, promote intracellular delivery of bio-active molecules, reduce the uptake of macrophages and encapsulate both hydrophilic as well as lipophillic drug molecule. In this review article, I try to give some basic knowledge about these carrier systems in tabular form, which is more understandable concept as compared to simple text form.
Export Options
About this article
Cite this article as:
Garg Tarun and K. Goyal Amit, Liposomes: Targeted and Controlled Delivery System, Drug Delivery Letters 2014; 4 (1) . https://dx.doi.org/10.2174/22103031113036660015
DOI https://dx.doi.org/10.2174/22103031113036660015 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Preface:
CNS & Neurological Disorders - Drug Targets Oxidative Stress and Antioxidative Enzyme Activities in Chronic Kidney Disease and Different Types of Renal Replacement Therapy
Current Protein & Peptide Science Renal Ischemia: How Commonly Does it Cause Renal Failure?
Current Hypertension Reviews Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Modulation of Mitochondrial Permeability Transition in Ischemia-Reperfusion Injury of the Heart. Advantages and Limitations
Current Medicinal Chemistry Metabolic Activation of Herbal and Dietary Constituents and Its Clinical and Toxicological Implications: An Update
Current Drug Metabolism Drugs of Abuse: Epigenetic Mechanisms in Toxicity and Addiction
Current Medicinal Chemistry AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
Current Drug Targets Acellular Spinal Cord Scaffold Implantation Promotes Vascular Remodeling with Sustained Delivery of VEGF in a Rat Spinal Cord Hemisection Model
Current Neurovascular Research Recent Advances in Health Promoting Effect of Dietary Polyphenols
Current Nutrition & Food Science The Cardiac Microvasculature in Hypertension, Cardiac Hypertrophy and Diastolic Heart Failure
Current Vascular Pharmacology Medicinal Agents in the Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Common Therapeutic Strategies for Diabetic Retinopathy and Glaucoma
Current Drug Therapy Non-Covalent Proteasome Inhibitors
Current Pharmaceutical Design FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
Current Neurovascular Research New Anti-Anginal Drugs: Ranolazine
Cardiovascular & Hematological Agents in Medicinal Chemistry Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation
Current Medicinal Chemistry Toll-Like Receptors in Alzheimer's Disease: A Therapeutic Perspective
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery